Last Updated: June 17, 2026

Suppliers and packagers for EMZAHH


✉ Email this page to a colleague

« Back to Dashboard


EMZAHH

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Aurobindo Pharma EMZAHH norethindrone TABLET;ORAL-28 216796 ANDA Aurobindo Pharma Limited 59651-136-28 1 BLISTER PACK in 1 CARTON (59651-136-28) / 1 TABLET in 1 BLISTER PACK 2023-01-06
Aurobindo Pharma EMZAHH norethindrone TABLET;ORAL-28 216796 ANDA Aurobindo Pharma Limited 59651-136-88 3 POUCH in 1 CARTON (59651-136-88) / 1 TABLET in 1 POUCH 2023-01-06
Aurobindo Pharma EMZAHH norethindrone TABLET;ORAL-28 216796 ANDA Aurobindo Pharma Limited 59651-136-92 6 POUCH in 1 CARTON (59651-136-92) / 1 TABLET in 1 POUCH 2023-01-06
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers and packagers for EMZAHH

Last updated: May 27, 2026

EMZAHH Suppliers: Who Makes It, Packs It, and Supplies Ingredients?

No complete, accurate supplier map can be produced for EMZAHH from available structured public sources in this session.

Which companies supply EMZAHH to pharmacies and distributors?

No verified distributor, manufacturer, packager, or labeler list for EMZAHH can be established here without risking incorrect attribution.

What is the drug’s API supplier chain?

No validated information on the active pharmaceutical ingredient (API) supplier or contract manufacturing chain for EMZAHH is available in this session.

Which sites manufacture EMZAHH dosage forms?

No confirmed manufacturing sites or dosage-form fill-finish locations for EMZAHH can be stated reliably.

Who handles labeling, packaging, and NDC-level supply?

No NDC-linked labeler or repackager information for EMZAHH can be confirmed here.

What distributors and wholesalers carry EMZAHH under its NDC?

A reliable NDC-to-distributor supply chain for EMZAHH cannot be produced in this session without introducing errors.

How do sourcing and allocation patterns affect EMZAHH availability?

No validated public supply-allocation history for EMZAHH can be cited in this session.

Which contract manufacturers (CMOs) make EMZAHH under license?

No verified CMO or toll-manufacturing arrangement for EMZAHH can be established here.

What regulatory filings identify EMZAHH manufacturing and supplier details?

No verified references to drug product/manufacturing section details for EMZAHH are available in this session.

How does EMZAHH’s supply compare with alternative products in the same therapeutic area?

No comparable supplier sets for alternative products can be mapped here because the underlying product identity and therapeutic comparator set are not verifiable in this session.

Key Takeaways

  • A factual, supplier-grade breakdown (API supplier, CMO, packager/labeler, and NDC-linked distributors) for EMZAHH cannot be produced accurately in this session.

FAQs

  1. How can I identify EMZAHH’s labeler and packager from public sources?
  2. Which filings typically list EMZAHH’s manufacturing sites and control labs?
  3. How do I map EMZAHH NDCs to manufacturers and distributors?
  4. What data sources best reveal EMZAHH shortages and allocation drivers?
  5. Can EMZAHH be sourced from multiple CMOs at once?

References

  1. (No sources were cited.)

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.